Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide

MLA

Jalleh, Ryan J., et al. “Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide.” The Journal of Clinical Endocrinology & Metabolism, vol. 110, no. 1, Jan. 2025, pp. 1–15. EBSCOhost, https://doi.org/10.1210/clinem/dgae719.

APA

Jalleh, R. J., Plummer, M. P., Marathe, C. S., Umapathysivam, M. M., Quast, D. R., Rayner, C. K., Jones, K. L., Wu, T., Horowitz, M., & Nauck, M. A. (2025). Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide. The Journal of Clinical Endocrinology & Metabolism, 110(1), 1–15. https://doi.org/10.1210/clinem/dgae719

Chicago

Jalleh, Ryan J, Mark P Plummer, Chinmay S Marathe, Mahesh M Umapathysivam, Daniel R Quast, Christopher K Rayner, Karen L Jones, Tongzhi Wu, Michael Horowitz, and Michael A Nauck. 2025. “Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide.” The Journal of Clinical Endocrinology & Metabolism 110 (1): 1–15. doi:10.1210/clinem/dgae719.